This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

JDP-205

Pfizer Inc.

Drug Names(s): JDP205

Description: JDP205 is a small molecule, non-sedating antihistamine.

Deal Structure: JDP and Hospira
On March 2016, JDP announced that it entered into a development, manufacture and supply agreement, for JDP-205, with Hospira (a Pfizer company). Under this agreement, Hospira will be responsible for the remaining CMC activities for JDP-205s NDA, including development and manufacture of JDP-205s registration & Phase III clinical batches; Hospira will also be responsible for manufacture and supply of commercial quantities of JDP- 205.

Partners: JDP Therapeutics, Inc.


JDP-205 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug